Tag: FINANCIAL INSTITUTIONS
Recent Articles
Hudson Yards Event Venue Files for Chapter 11 Bankruptcy
Hudson Mercantile, the iconic event space in Manhattan's Hudson Yards, has filed for Chapter 11 bankruptcy. The company faced financial challenges brought...
New High Yield Bond Ratings October 19 – October 23, 2020
At least 12 companies received downgrades or revisions on high yield bond ratings during the week of October 19 – October 23,...
Euronext Acquires Borsa Italiana in $5.1 Billion Deal
Euronext has acquired Borsa Italiana in a $5.1 billion deal. The London Stock Exchange is the entity that facilitated the deal. The...
Scottsdale Community Bank to Become Arizona’s Newest Community Bank
The Federal Deposit Insurance Corporation (FDIC) has given Scottsdale Community Bank (SCB) conditional approval to open as Arizona's first new community bank...
McAfee Reenters Stock Market with IPO of $20
McAfee Inc, the software company best known for their firewall program, reentered public domain with an IPO of $20 on Wednesday. With...
Most Popular
New Chapter 11 Filings, Disclosures: August 3 – August 7, 2020
At least six new companies have either filed for Chapter 11 bankruptcy protection or defaulted on loans during the week of August...
New Chapter 11 Filings, Disclosures: October 5 – October 9, 2020
At least five major companies have either filed for Chapter 11 bankruptcy protection or defaulted on loans during the week of October...
Acquisition of GrubHub Extended
Netherlands-based JustEat Takeaway announced the acquisition of GrubHub for $7.3 billion. JustEat will buy 100 percent of the Chicago-based service in an...
Kymera Therapeutics Announces $102 Million Series C Financing
Kymera Therapeutics Inc., a biotechnology company pioneering targeted protein degradation to invent breakthrough protein degrader medicines for patients, today announced the closing...
VIVUS Pre-Packaged Bankruptcy Plan Rejected by Courts
Pre-packaged bankruptcies typically allow for an expedited Chapter 11 process. But that was not the case for biopharmaceutical company VIVUS, Inc (NYSE:...
